Cargando…
PD-L1 is a critical mediator of regulatory B cells and T cells in invasive breast cancer
Regulatory T cells (Tregs), a key mediator in regulating anti-tumor immune suppression, tumor immune escape, metastasis and relapse, are considered an important therapeutic target in immunotherapy of human cancers. In the present investigation, elevated CD19(+) CD24(+) CD38(+) regulatory B cells (Br...
Autores principales: | Guan, Honggeng, Wan, Yuqiu, Lan, Jing, Wang, Qin, Wang, Zhangyu, Li, Yecheng, Zheng, Jiqing, Zhang, Xueguang, Wang, Zemin, Shen, Yueping, Xie, Fang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5071845/ https://www.ncbi.nlm.nih.gov/pubmed/27762298 http://dx.doi.org/10.1038/srep35651 |
Ejemplares similares
-
The interaction between the soluble programmed death ligand-1 (sPD-L1) and PD-1(+) regulator B cells mediates immunosuppression in triple-negative breast cancer
por: Li, Xuejiao, et al.
Publicado: (2022) -
Regulatory B cells induced by pancreatic cancer cell-derived interleukin-18 promote immune tolerance via the PD-1/PD-L1 pathway
por: Zhao, Yan, et al.
Publicado: (2017) -
PD-1 restraint of regulatory T cell suppressive activity is critical for immune tolerance
por: Tan, Catherine L., et al.
Publicado: (2020) -
Examining the antecedents and consequences of mobile travel app engagement
por: Tian, Zemin, et al.
Publicado: (2021) -
Regulatory Effect of PD1/PD-Ligand 1 (PD-L1) on Treg Cells in Patients with Idiopathic Pulmonary Fibrosis
por: Wang, Bing, et al.
Publicado: (2021)